Prospective Study
Copyright ©The Author(s) 2017.
World J Hepatol. Jun 8, 2017; 9(16): 746-751
Published online Jun 8, 2017. doi: 10.4254/wjh.v9.i16.746
Table 1 Demographic data and laboratory parameters of biliary atresia patients based on status of jaundice
BA patientsTotalJaundiceNo jaundiceP-value
n702842
Gender (male/female)30:4012:1618:240.5
Age (yr)7.6 ± 0.56.3 ± 0.88.6 ± 0.60.01
Albumin (g/dL)3.9 ± 0.13.2 ± 0.34.3 ± 0.1< 0.001
Total bilirubin (mg/dL)3.8 ± 0.78.2 ± 1.50.9 ± 0.1< 0.001
Direct bilirubin (mg/dL)2.5 ± 0.65.8 ± 1.10.2 ± 0.1< 0.001
AST (IU/L)148.8 ± 13.7235.9 ± 20.990.8 ± 11.3< 0.001
ALT (IU/L)133.3 ± 12.8183.4 ± 18.499.8 ± 15.70.001
ALP (IU/L)501.7 ± 36.3681.6 ± 46.3381.8 ± 43.3< 0.001
25(OH)D (ng/mL)25.3 ± 1.116.0 ± 1.830.1 ± 0.7< 0.001
Lumbar BMD (g/cm2)0.5 ± 0.00.4 ± 0.00.6 ± 0.0< 0.001
Lumbar BMD Z-score-1.2 ± 0.2-2.3 ± 0.2-0.4 ± 0.1< 0.001
Table 2 Comparison of clinical characteristics and laboratory parameters among biliary atresia patients with normal, osteopenic, and osteoporotic bone mineral density Z-scores at the lumbar spine
CharacteristicsNormalOsteopeniaOsteoporosisP-value
n341818
Gender (male/female)15/197/118/100.3
Age (yr)8.2 ± 0.77.7 ± 1.16.5 ± 1.00.4
Albumin (g/dL)4.1 ± 0.24.0 ± 0.13.3 ± 0.2< 0.05
Total bilirubin (mg/dL)1.0 ± 0.22.8 ± 0.710.0 ± 2.1< 0.001
Direct bilirubin (mg/dL)0.4 ± 0.11.6 ± 0.57.3 ± 1.7< 0.001
AST (IU/L)95.6 ± 13.7177.1 ± 24.8221.2 ± 31.2< 0.001
ALT (IU/L)104.2 ± 18.2164.6 ± 23.7156.8 ± 25.1< 0.001
ALP (IU/L)429.1 ± 55.7538.4 ± 55.2602.3 ± 71.30.08
25(OH)D (ng/mL)33.2 ± 0.726.3 ± 0.514.3 ± 1.5< 0.01
Lumbar BMD (g/cm2)0.6 ± 0.00.5 ± 0.00.4 ± 0.0< 0.001